MICHAEL WHITE to Protein Kinase Inhibitors
This is a "connection" page, showing publications MICHAEL WHITE has written about Protein Kinase Inhibitors.
Connection Strength
0.136
-
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov. 2017 08; 7(8):832-851.
Score: 0.100
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature. 2022 06; 606(7915):797-803.
Score: 0.036